- Home
- NA vs XTNT Comparison
NA vs XTNT Comparison
Compare NA & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NA
- XTNT
- Stock Information
- Founded
- NA 2019
- XTNT N/A
- Country
- NA China
- XTNT United States
- Employees
- NA N/A
- XTNT N/A
- Industry
- NA Semiconductors
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NA Technology
- XTNT Health Care
- Exchange
- NA Nasdaq
- XTNT Nasdaq
- Market Cap
- NA 95.7M
- XTNT 112.1M
- IPO Year
- NA 2022
- XTNT N/A
- Fundamental
- Price
- NA $4.65
- XTNT $0.90
- Analyst Decision
- NA
- XTNT
- Analyst Count
- NA 0
- XTNT 0
- Target Price
- NA N/A
- XTNT N/A
- AVG Volume (30 Days)
- NA 94.8K
- XTNT 349.1K
- Earning Date
- NA 08-15-2025
- XTNT 11-07-2025
- Dividend Yield
- NA N/A
- XTNT N/A
- EPS Growth
- NA N/A
- XTNT N/A
- EPS
- NA N/A
- XTNT N/A
- Revenue
- NA $3,369,693.00
- XTNT $127,766,000.00
- Revenue This Year
- NA N/A
- XTNT $13.03
- Revenue Next Year
- NA N/A
- XTNT N/A
- P/E Ratio
- NA N/A
- XTNT N/A
- Revenue Growth
- NA N/A
- XTNT 15.16
- 52 Week Low
- NA $2.77
- XTNT $0.33
- 52 Week High
- NA $31.48
- XTNT $0.93
- Technical
- Relative Strength Index (RSI)
- NA 37.39
- XTNT 71.37
- Support Level
- NA $4.61
- XTNT $0.68
- Resistance Level
- NA $5.97
- XTNT $0.89
- Average True Range (ATR)
- NA 0.36
- XTNT 0.07
- MACD
- NA -0.07
- XTNT 0.01
- Stochastic Oscillator
- NA 8.33
- XTNT 88.19
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.